ArticleMedical physics2026
A coarse-to-fine framework combining deep learning and Monte Carlo for BNCT patient position optimization toward inverse planning.
Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundBoron Neutron Capture Therapy (BNCT) utilizes high linear energy transfer (LET) charged particles from the PURPOSE: We propose an automated patient position optimization framework for BNCT to address these limitations. This method overcomes the computational bottleneck of MC simulations by integrating a rapid deep learning (DL) dose prediction model with a high-fidelity GPU-accelerated MC engine, enabling efficient inverse planning.
methodsWe developed a hybrid coarse-to-fine optimization workflow driven by the Trust Region Bayesian Optimization (TuRBO) algorithm. In the coarse stage, a 3D U-Net architecture rapidly identifies promising patient positions. In the fine stage, the solution is refined within a restricted parameter bound using the GPU-accelerated MC engine. We evaluated the framework on the GLIS-RT open dataset (229 glioblastoma patients, split into train, validation, and test sets at a 70:20:10 ratio).
resultsOptimizing the patient position with TuRBO improved target dose and homogeneity over a non-optimized baseline, reaching equivalent plan quality about 5.65× faster than an exhaustive grid search. In the coarse stage, the DL dose predictor ran about 37× faster than the high-fidelity MC. The coarse-to-fine workflow then matched high-fidelity MC plan quality while cutting optimization time by a factor of 2.7, outperforming optimization driven by the DL predictor alone. Two-port plans required no change to the method, where the added geometric freedom raised the mean target dose from 59.96% to 74.91% and lowered the homogeneity index (HI) from 1.226 to 0.647.
conclusionsWe successfully developed a Bayesian optimization (BO) framework for BNCT patient positioning. The proposed coarse-to-fine approach effectively balances computational speed with accuracy, offering a practical way toward automated inverse planning in BNCT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.